Neurotoxicity Syndromes

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-12-09
Clinical Trial Update: A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity [Phase 2]
Phase 2 safety and efficacy study of Defibrotide for preventing CAR-T cell–associated neurotoxicity in patients with DLBCL; study TERMINATED…